Potential treatment benefits and safety of roflumilast in COPD: a systematic review and meta-analysis
about
Synergy between 5-HT4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle.Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP+-induced decline of mitochondrial membrane potential and oxidative stress.Phosphodiesterase type 4 inhibition enhances nitric oxide- and hydrogen sulfide-mediated bladder neck inhibitory neurotransmission.
P2860
Potential treatment benefits and safety of roflumilast in COPD: a systematic review and meta-analysis
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Potential treatment benefits a ...... matic review and meta-analysis
@ast
Potential treatment benefits a ...... matic review and meta-analysis
@en
Potential treatment benefits a ...... matic review and meta-analysis
@nl
type
label
Potential treatment benefits a ...... matic review and meta-analysis
@ast
Potential treatment benefits a ...... matic review and meta-analysis
@en
Potential treatment benefits a ...... matic review and meta-analysis
@nl
prefLabel
Potential treatment benefits a ...... matic review and meta-analysis
@ast
Potential treatment benefits a ...... matic review and meta-analysis
@en
Potential treatment benefits a ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P921
P3181
P356
P1476
Potential treatment benefits a ...... matic review and meta-analysis
@en
P2093
P2860
P304
P3181
P356
10.2147/COPD.S106370
P407
P577
2016-01-01T00:00:00Z
2016-06-30T00:00:00Z